Osagie has over 30 years of experience in the field of law, finance and business management, health-care and the
pharmaceutical industry. Prior to co-founding Phoenix IP Ventures, Osagie conceptualized and established GlaxoSmithKline Ventures
and was its founding Vice President. Osagie led GSK Ventures in concluding over thirty (30) worldwide transactions, within a 3 year period,
in which he invested various GSK R&D non-progressed assets into various companies and/or as the basis of starting new companies.
Prior to this role within GSK, Osagie was a Vice President for Product Development Strategy at SmithKline Beecham. Prior to this role at SmithKline,
Osagie was the founding Senior Vice President for Business Development and General Counsel at Endo Pharmaceuticals Inc., a multi-billion dollar publicly
traded specialist pharmaceutical company. Osagie previously served as a DuPont Merck Vice President for International Sales and Marketing and General Counsel
to DuPont Merck's International, Manufacturing and Generic Drug Divisions, Osagie has also been a Price Waterhouse Corporate Finance Partner as well as a
practicing attorney with a leading US Law Firm in the fields of corporate, corporate finance, taxation and intellectual property law.
Most recently, Osagie was a co-founder and former President, CEO and Chairman of Ception Therapeutics Inc., a biopharmaceutical focused on the discovery and
development of novel products to address unmet medical needs, which was successfully sold to Cephalon, Inc. Osagie, was also the Founder of Trigenesis Therapeutics Inc.,
a biopharmaceutical company focused on developing pharmaceutical products for the dermatological market which he sold to a publicly traded pharmaceutical company. Osagie
is Executive Chairman of the Board of Directors of Iroko Pharmaceuticals as well as Chairman of iCeutica Inc. In addition, he serves on the Board of a number of financial
institutions such as StoneRidge Investment Partners and Haverford Trust. Osagie is also the Chairman of the Advisory Board for Quoin Capital, A Philadelphia based, full
services Investment Bank.
Osagie is active in charitable and community pursuits and serves as a Board and Executive Committee member of the Philadelphia Museum of Art and the Philadelphia Orchestra.
In addition, he is a Trustee of the University of Pennsylvania and also a member of the Board of Overseers of the University of Pennsylvania Law School, where he is an Adjunct
Professor of Law.